Pillar Biosciences: Pilar Biosciences seeks to make precision medicine a first-line therapy for cancer patients
Randy Pritchard, Pillar Biosciences CEO, highlighted some of the progress the oncology solutions company has made in developing in-vitro diagnostics in response to emailed questions from MedCity News.
Read full article »
Pillar Biosciences is a Massachusetts-based biotechnology company that provides solutions such as cell-free DNA analysis, liquid biopsy and next-generation sequencing.
Read more